# A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance

> **NCT06313255** · — · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** PegIFNα2b
- **DRUG:** PegIFNα2b+probiotics
- **DRUG:** Nucleoside analog
- **DRUG:** Nucleoside analog+probiotics

## Key facts

- **NCT ID:** NCT06313255
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-09
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06313255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06313255, "A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06313255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*